The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Takeda Canada Inc., the Canadian organization of Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that non-profit ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and ...

This latter effect is important both because therapy in CIDP is usually episodic and because IVIg is typically a more expensive treatment and indefinite monthly infusions would be quite resource ...

Aim: To report the interesting case of a patient with common variable immune deficiency disease who demonstrated varied responses to intravenous (IV) and subcutaneous (SC) immunoglobulin (Ig ...

After gaining FDA approval for Leqembi, Eisai continued testing the drug to see whether it can be given as an injection to people who have never taken it, as well as to people who started on the IV ...

Your body can produce an infinite number of binding sites to bind to antigens. Immunoglobulin G (IgG) accounts for around 75% of all antibodies in the human body. Depending on the antigen, IgG can ...

“I will be transparent,” says the designer Azeeza Khan. “The first time I heard about NAD+ was because Hailey Bieber was doing it.” The model was filmed sampling an intravenous drip laced with ...